OGN - CIK 0001821825
The table below shows Organon & Co.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | $225.00M | $75.00M | $76.00M | $114.00M | $123.00M | - |
| Capital expenditure | $37.00M | $32.00M | $46.00M | $46.00M | $33.00M | $38.00M |
| Investing cash flow | $386.00M | -$172.00M | -$96.00M | -$54.00M | -$63.00M | - |
| Dividends paid | $5.00M | $71.00M | $70.00M | $73.00M | $71.00M |
Organon & Co. reported operating cash flow of $700.00M for fiscal year 2025. That is down 25.5% from $939.00M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $0.00 |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$38.00M | -$75.00M | -$74.00M | -$326.00M | -$91.00M | - |